Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

354 studies match

clinicaltrialsPublishedShowing 251–300 of 354 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06819007	Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)(DO-01)	recruiting	Phase 3	582	Daiichi SankyoINDUSTRY	25	Jul 2, 2026	clinicaltrials
NCT07680699	NEOSENT: Early Anti-PD-1 Therapy In High-Risk Stage II Melanoma(NEOSENT)	recruiting	—	250	AC Camargo Cancer CenterOTHER	1